Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 8
2005 5
2006 12
2007 11
2008 2
2009 7
2010 7
2011 9
2012 11
2013 13
2014 15
2015 5
2016 10
2017 12
2018 10
2019 9
2020 13
2021 13
2022 20
2023 28
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors.
Clemente T, Galli L, Lolatto R, Gagliardini R, Lagi F, Ferrara M, Cattelan AM, Focà E, Di Biagio A, Cervo A, Calza L, Maggiolo F, Marchetti G, Cenderello G, Rusconi S, Zazzi M, Santoro MM, Spagnuolo V, Castagna A; PRESTIGIO Study Group. Clemente T, et al. Among authors: galli l. BMJ Open. 2024 Feb 10;14(2):e080606. doi: 10.1136/bmjopen-2023-080606. BMJ Open. 2024. PMID: 38341206 Free PMC article.
Lower aids-related hospitalizations in women living with HIV multidrug resistance.
Papaioannu Borjesson R, Galli L, Lolatto R, Menzaghi B, Feasi M, Gulminetti R, Fornabaio C, Cattelan AM, Bonora S, Lagi F, Zazzi M, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Papaioannu Borjesson R, et al. Among authors: galli l. AIDS. 2024 Mar 1;38(3):435-438. doi: 10.1097/QAD.0000000000003781. Epub 2024 Feb 1. AIDS. 2024. PMID: 38300163 No abstract available.
Clinical Efficacy of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis in Immunocompromised Patients Treated During Omicron Sublineages Diffusion. Real-Life Experience from ASST Lecco.
Conti F, Pontiggia S, Morena V, Alberton F, Badalucco F, Molteni C, Bradanini L, Pandolfo A, Galli L, Castagna A, Piconi S. Conti F, et al. Among authors: galli l. Am J Med. 2024 Feb;137(2):e40-e41. doi: 10.1016/j.amjmed.2023.09.005. Am J Med. 2024. PMID: 38296410 No abstract available.
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies.
Mori G, Diotallevi S, Farina F, Lolatto R, Galli L, Chiurlo M, Acerbis A, Xue E, Clerici D, Mastaglio S, Lupo Stanghellini MT, Ripa M, Corti C, Peccatori J, Puoti M, Bernardi M, Castagna A, Ciceri F, Greco R, Oltolini C. Mori G, et al. Among authors: galli l. Microorganisms. 2024 Jan 6;12(1):117. doi: 10.3390/microorganisms12010117. Microorganisms. 2024. PMID: 38257945 Free PMC article. Review.
Mpox DNA clearance in semen over 6-month follow-up.
Candela C, Galli L, Rizzo A, Mileto D, Canetti D, Gianotti N, Raccagni AR, Bertoni C, Lucente MF, Gismondo MR, Castagna A, Nozza S. Candela C, et al. Among authors: galli l. J Med Virol. 2023 Dec;95(12):e29259. doi: 10.1002/jmv.29259. J Med Virol. 2023. PMID: 38037499
207 results